Literature DB >> 23519381

[What is the actual benefit of sigmoid resection for acute diverticulitis? : Functional outcome after surgical and conservative treatment].

J-P Ritz1, J Gröne, S Engelmann, K S Lehmann, H J Buhr, C Holmer.   

Abstract

INTRODUCTION: The correct therapeutic management of acute sigmoid diverticulitis (SD) is still controversially discussed. Essential to the success of therapy is primarily the long-term resolution of Patient symptoms after surgical or conservative therapy. The aim of this study was to compare the long-term outcome after conservative and surgical treatment of Patients with acute SD. PATIENTS AND METHODS: Consecutive admissions of all Patients with acute SD were prospectively recruited from January 2005 to June 2008 with the exception of a free perforation. The following data were recorded: age, sex, first or recurrent episode of SD, computed tomography (CT) stage, white blood cell count, C-reactive protein, persistent symptoms and recurrence after conservative and surgical therapy. Furthermore, information on the rates of postoperative sexual and bladder dysfunction was collected. The long-term outcome was evaluated by a standardized questionnaire. In June 2008 all Patients were contacted using a standardized questionnaire.
RESULTS: A total of 153 Patients were included in the study of whom 70 (45.8  %) presented with the first episode, 83 (54.2  %) had a prior history of SD and 40 Patients were treated conservatively whereas 113 Patients were surgically treated by sigmoid resection. Uncomplicated SD was seen in 16 Patients (conservative 4, surgical 12, p = 0.961), phlegmonous SD was seen in 88 cases (conservative 29, surgical 59, p = 0.026) and covered perforated SD in 49 cases (conservative 7, surgical 42, p = 0.022). The median follow-up was 32 months (range 12-52 months). At follow-up 25  % of conservative and 8.8  % of Patients treated surgically complained about persistent symptoms (p = 0.009). The following symptoms occurred (conservative vs. surgery): painful defecation (22.5  % versus 8.8  %, p = 0.024.), constipation (25  % versus 8.8  %, p = 0.009), abdominal cramp (22.5 % versus 4.4  %, p = 0.001) and painful flatulence (25  % versus 8.8  %, p = 0.009). Sexual or bladder dysfunction occurred postoperatively in 7  % and 9  %, respectively. Of the conservatively treated Patients 32.5  % had a recurrence of SD during follow-up compared to 3.5 % of surgically treated Patients (p < 0.001).
CONCLUSIONS: Surgical treatment of acute SD is more effective than conservative therapy for the prophylaxis of recurrent SD and avoidance of persistent symptoms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23519381     DOI: 10.1007/s00104-013-2485-0

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  32 in total

1.  Elective resection for diverticular disease of the sigmoid colon.

Authors:  J Moreaux; C Vons
Journal:  Br J Surg       Date:  1990-09       Impact factor: 6.939

2.  Practice parameters for sigmoid diverticulitis.

Authors:  Janice Rafferty; Paul Shellito; Neil H Hyman; W Donald Buie
Journal:  Dis Colon Rectum       Date:  2006-07       Impact factor: 4.585

Review 3.  Epidemiology of diverticular disease.

Authors:  Stephanie Jun; Neil Stollman
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-08       Impact factor: 3.043

4.  Diverticular disease of the large bowel in Singapore. An autopsy survey.

Authors:  Y S Lee
Journal:  Dis Colon Rectum       Date:  1986-05       Impact factor: 4.585

5.  Minimally invasive colon resection (laparoscopic colectomy).

Authors:  M Jacobs; J C Verdeja; H S Goldstein
Journal:  Surg Laparosc Endosc       Date:  1991-09

6.  Sigmoid diverticulitis in young patients--a more aggressive disease than in older patients?

Authors:  Jörg-Peter Ritz; Kai S Lehmann; Andrea Stroux; Heinz J Buhr; Christoph Holmer
Journal:  J Gastrointest Surg       Date:  2011-02-12       Impact factor: 3.452

Review 7.  Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the available evidence.

Authors:  George Peppas; Ioannis A Bliziotis; Dora Oikonomaki; Matthew E Falagas
Journal:  J Gastroenterol Hepatol       Date:  2007-09       Impact factor: 4.029

Review 8.  Sexual function, incontinence, and wellbeing in women after rectal cancer--a review of the evidence.

Authors:  Mary Panjari; Robin J Bell; Susan Burney; Stephen Bell; Paul J McMurrick; Susan R Davis
Journal:  J Sex Med       Date:  2012-08-20       Impact factor: 3.802

Review 9.  Surgery for complicated diverticulitis.

Authors:  D A Rothenberger; O Wiltz
Journal:  Surg Clin North Am       Date:  1993-10       Impact factor: 2.741

10.  Diverticulitis. A comprehensive follow-up.

Authors:  K D Munson; M A Hensien; L N Jacob; A M Robinson; W A Liston
Journal:  Dis Colon Rectum       Date:  1996-03       Impact factor: 4.585

View more
  5 in total

1.  [Unusual differential diagnosis of posttraumatic back pain].

Authors:  H Siekmann; D Adler; R Schneider; K Weinitschke; A G Bach
Journal:  Unfallchirurg       Date:  2014-11       Impact factor: 1.000

Review 2.  Management of sigmoid diverticulitis: an update.

Authors:  Patrick Ambrosetti; Pascal Gervaz
Journal:  Updates Surg       Date:  2016-04-16

Review 3.  Elective Surgery for Sigmoid Diverticulitis - Indications, Techniques, and Results.

Authors:  Christian F Jurowich; Christoph T Germer
Journal:  Viszeralmedizin       Date:  2015-04-09

4.  Quality of life in uncomplicated recurrent diverticulitis: surgical vs. conservative treatment.

Authors:  Viktor Justin; Selman Uranues; Hans Rabl; Abe Fingerhut
Journal:  Sci Rep       Date:  2020-06-24       Impact factor: 4.379

5.  Validation of the German Classification of Diverticular Disease (VADIS)-a prospective bicentric observational study.

Authors:  Johannes C Lauscher; Johan F Lock; Katja Aschenbrenner; Rahel M Strobel; Marja Leonhardt; Andrea Stroux; Benjamin Weixler; Christoph-Thomas Germer; Martin E Kreis
Journal:  Int J Colorectal Dis       Date:  2020-09-04       Impact factor: 2.571

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.